Inmunómica traslacional en neoplasias hematológicas
Foundation for the National Institutes of Health
Bethesda, Estados UnidosFoundation for the National Institutes of Health-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Minimal residual disease in Myeloma: Application for clinical care and new drug registration
Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212